SEARCH

SEARCH BY CITATION

References

  • 1
    Bruehl S, Harden RN, Galer BS, et al. Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome? Pain 2002;95:11924.
  • 2
    Sandroni P, Benrud-Larson LM, McClelland RL, et al. Complex regional pain syndrome type I: incidence and prevalence in Olmsted County, a population-based study. Pain 2003;103:199207.
  • 3
    Forouzanfar T, Kemler MA, Weber WE, et al. Spinal cord stimulation in complex regional pain syndrome: cervical and lumbar devices are comparably effective. Br J Anaesth 2004;92:34853.
  • 4
    Perez RS, Kwakkel G, Zuurmond WW, et al. Treatment of reflex sympathetic dystrophy (CRPS type 1): a research synthesis of 21 randomized clinical trials. J Pain Symptom Manage 2001;21:51126.
  • 5
    Stanton-Hicks M. Complex regional pain syndrome: manifestations and the role of neurostimulation in its management. J Pain Symptom Manage 2006;31(Suppl.):S204.
  • 6
    Kemler MA, Barendse GA, Van Kleef M, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med 2000;343:61824.
  • 7
    Kemler MA, De Vet HC, Barendse GA, et al. The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Ann Neurol 2004;55:1318.
  • 8
    Kemler MH, De Vet HC, Barendse GA, et al. Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. J Neurosurg 2008;108:2928.
  • 9
    Taylor RS, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ 2004;23:97275.
  • 10
    Detsky AS, Laupacis A. Relevance of cost-effectiveness analysis to clinicians and policy makers. JAMA 2007;298:22124.
  • 11
    NICE. Spinal Cord Stimulation for Chronic Pain of Neuropathic Or Ischaemic Origin. London: National Institute for Health and Clinical Excellence, 2008. Available from: http://www.nice.org.uk/Guidance/TA159[Accessed September 30, 2009].
  • 12
    Merskey H, Bogduk N. Classification of chronic pain. In: MerskeyH, BogdukN, eds. Descriptions of Chronic Pain Syndromes and Definition of Pain Terms (2nd ed.). Seattle, WA: IASP Press, 1994.
  • 13
    Taylor RJ, Taylor RS. Spinal cord stimulation for failed back surgery syndrome: a decision-analytic model and cost-effectiveness analysis. Int J Technol Assess Health Care 2005;21:3518.
  • 14
    Kumar K, Hunter G, Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience. Neurosurgery 2006;58:4816.
  • 15
    Dolan P. Modelling valuations for EuroQoL health states. Med Care 1997;35:1095108.
  • 16
    Kumar K, Taylor RS, Jacques L, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain 2007;132:17988.
  • 17
    Manca A, Kumar K, Taylor RS, et al. Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS Trial). Eur J Pain 2008;12:104758.
  • 18
    NICE. Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence, 2008. Available from: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf[Accessed September 30, 2009].
  • 19
    Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:77987.
  • 20
    Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004;329:2247.
  • 21
    Kemler MA, Furnée CA. Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology 2002;59:12039.
  • 22
    Simpson EL, Duenas A, Holmes MW, et al. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation. Health Technol Assess 2009;13(iii):ixx, 1–154.
  • 23
    Hornberger J, Kumar K, Verhulst E, et al. Rechargeable spinal cord stimulation versus non-rechargeable systems for patients with failed back surgery syndrome: a cost-consequences analysis. Clin J Pain 2008;24:24452.
  • 24
    Taylor RS. Epidemiology of refractory neuropathic pain. Pain Pract 2006;6:226.
  • 25
    National Health Service England, Hospital Episodes Statistics. Totals report for Procedure A483 (Insertion of neurostimulator adjacent to spinal cord) for the all SHA's (Strategic Health Authorities) of treatment. 2005/06. Available from: http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937[Accessed May 7, 2010].
  • 26
    UK Office of National Statistics. Available from: http://www.statistics.gov.uk[Accessed September 30, 2009].